gip/glp-1 receptor agonist GLP-1 agonists approved for clinical use. GLP-1 agonists are available Effects of tirzepatide, a dual
Description
Discontinuation of TANZEUM [letter]
Funding This work did not receive any funding
PKA directly phosphorylates sulfonylurea receptor 1 (SUR1), a regulatory subunit of voltage-dependent K + channels and KATP channels, increasing membrane depolarization and voltage-gated Ca 2+ channel activation
Consent to participate No consent is needed, as the study did not involve human participants
As a dual GIP/GLP-1 receptor agonist, it targets two hormonal pathways instead of one
Ludvik B, Giorgino F, Jodar E, Frias JP, Fernandez Lando L, Brown K
